openPR Logo
Press release

Drug Integrated Polymer Fibers Market 2019 Regional Trend & Growth Projections to 2025

07-10-2019 11:31 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: global market insights

Drug Integrated Polymer Fibers Market

Drug Integrated Polymer Fibers Market

The drug integrated polymer fibers market is expected to witness an accelerated growth rate over the next few years, propelled by the surging number of vascular disorder patients, in addition to applications in orthopedic, drug delivery and would healing segments. Rapid development in the field of biocompatible materials, fast 3D printing of medical and surgical devices as well as in healthcare infrastructure will offer a tremendous boost to the expanding drug integrated polymer fibers industry.

The growing number of investments in R&D activities of novel healthcare solutions has majorly propelled drug integrated polymer fibers market, concurrent with rising prevalence of various orthopaedic, vascular and other disorders. Unprecedented advances in synthetic and biodegradable medical devices and materials have enabled the infusion of pharmaceutical properties within key surgical products.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/3103

The drug integrated polymer fibers industry is anticipated to gain massive advantages from the increasing disposable incomes of consumers, who can afford new and innovative treatment options. With the worldwide consumption of unhealthy food exacerbating every year, along with smoking and drinking habits, cases of obesity and cardiovascular diseases would only increase. Subsequently, the need for performing effective surgeries to treat life-threatening disorders will create a demand for vascular grafts and stents offered by the drug integrated polymer fibers market.

As a rule, constant innovations have always ensured that patients are benefited by the availability of efficient and long-lasting medical treatments. Albeit being only an emerging sector with very few established players, the drug integrated polymer fibers industry is showing signs of becoming a vital component of numerous inpatient procedures.

Many patients require the use of medical fibers or textile materials to support the treatment, cover a wound or be used as permanent fixtures inside the body. Now, essential drugs like antiseptics, painkillers or antibiotics can be administered to patients without the need for supervision, by utilizing polymers infused with the drugs. Devices such as vascular stents and vascular grafts could be a key application area for the drug integrated polymer fibers market, due to the rising occurrence of diseases like atherosclerosis.

Browse Report Summery @ https://www.gminsights.com/industry-analysis/drug-integrated-polymer-fibers-market

Atherosclerosis, essentially, results from the narrowing and hardening of arteries, most probably due to the buildup of cholesterol, calcium, fats, among other substances, in turn leading to increased chances of stroke, amputation or even death. Although changing one’s lifestyle to incorporate healthier eating habits, physical activity and stopping to smoke can help lower the risk of atherosclerosis, people who are diagnosed with the disorder may need to opt for surgery more often then not.

It has been reported that atherosclerosis-related diseases are a leading cause of fatalities in the U.S. and nearly 5 million people in the country are affected by it. With the two important treatments for the disease being surgical bypass or angioplasty, the drug integrated polymer fibers market could witness considerable growth from synthetic or bio-based grafts and stents used in the procedures.

Vascular stents are placed inside a blocked artery for keeping it open after an angioplasty procedure, including the treatment of cardiovascular blockages. These stents are increasingly being coated with medications to avoid the formation of blood clots in the stent, besides any other medicines necessary.

Drug-infused polymers have presented a significant solution to provide patients with the required dosage of medicines quickly, while simultaneously increasing the longevity of the treatment. Vascular stents are also known to reduce the chances of restenosis, which is the reoccurrence of narrowing of the arteries, by up to 15%. Interestingly, reports indicate that drug-releasing stents have the ability to reduce the risk of restenosis to less than 10%, which is a remarkable achievement considering the nature of the disorder.

Make an Inquiry for purchasing this Report @ https://www.gminsights.com/inquiry-before-buying/3103

Surgical bypass, performed to treat vascular blockage in different parts of the body such as the leg and abdomen, involves routing blood flow from an area affected by peripheral arterial disease, using a synthetic or natural graft. Even here, there is a risk of blood clotting as well as wound, bladder and other infections.

Undoubtedly, mitigating these risks could become a major focus for vascular graft producers, offering opportunities for the drug integrated polymer fibers industry to provide medically reinforced material to be used in the bypass. Further, since the lifespan of the procedure is considerably dependent on the health of the arteries, administering necessary drugs through the graft to avoid any complications could be of great importance.

All in all, the drug integrated polymer fibers market is expected to witness an accelerated growth rate over the next few years, propelled by the surging number of vascular disorder patients, in addition to applications in orthopedic, drug delivery and would healing segments. Rapid development in the field of biocompatible materials, fast 3D printing of medical and surgical devices as well as in healthcare infrastructure will offer a tremendous boost to the expanding drug integrated polymer fibers industry.

Contact Us:

Contact Person: Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone:1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: www.gminsights.com

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Integrated Polymer Fibers Market 2019 Regional Trend & Growth Projections to 2025 here

News-ID: 1800608 • Views: 99

More Releases from global market insights

Acoustic Diaphragm Market slated to observe traction for polypropylene material …
With a seismic rise in the demand for consumer products such a loudspeakers, mobile phones and earphones, acoustic diaphragm market size is slated to surge in the next five years. Notably, acoustic diaphragm tends to inter-convert mechanical vibration to sounds and has become highly popular in headphones and speakers. Market penetration of materials such as paper, polycarbonate, polypropylene, carbon fiber and aluminum has become more pronounced in the past several
How will increasing demand for stainless steel transform the Ferroalloys Market …
One of the recent breakthroughs in the global ferroalloys market is the potential acquisition of Ferro Alloys Corporation by Vedanta- a natural resource company early this year. As per reliable sources, the acquisition is expected to complement Vedanta’s current steel business considering the fact that integration of Ferro manufacturing capabilities would offer the possibility to generate significant efficiencies. Meanwhile, yet other company, Boston Metal has declared having raised over USD 20
Polyphenylsulfone Market 2021 | Regional Insights & Growth Forecast To 2025
The polyphenylsulfone market will witness significant expansion with the rise in healthcare concerns and the growing requirement for biocompatible products. Polyphenylsulfone is a high-performance thermoplastic that is amorphous, heat-resistant, and transparent. It showcases high sterilization properties and is widely employed as an alternative for polyetheretheketone and polyaryletherketone. Furthermore, the polymer sees large adoption across various verticals of the healthcare sector to offer superior dimensional stability and higher resistance against
Cosmetic Contact Lens Market 2021: Industry Growth, Competitive Analysis, Future …
Increasing trend of using colored contact lenses may have a positive impact on cosmetic contact lens market outlook. Rising popularity of customized lenses with attractive colors, shades and textures for improving eye appearance is likely to propel industry size. Proliferation of entertainment, online and social media platforms are helping boost the adoption of such lenses. Cosmetic contact lenses are available in several colors such as blue, green, brown, hazel, grey, violet

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning